Repairify's plans for upcoming training institute unveiled during 2022 SEMA press conference PLANO, Texas, Nov. 3, 2022 /PRNewswire/ -- Repairify™, Inc., a portfolio company of Kinderhook...

At this year's Appian Government conference, Appian (Nasdaq: APPN) announced the winners of its 2022 Public Sector Partner Impact and Excellence Awards and Solutions Cup winners. These annual...

Annual User Conference Draws Attendees from the Hospital, Physician Advisor and Payer Spaces for Three Days of Experiential Learning NASHVILLE, Tenn., Nov. 3, 2022 /PRNewswire/ -- XSOLIS, the...

CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation and two poster presentations from the Company's pacritinib program at the 64th American Society of Hematology (ASH®) Annual...

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the acceptance of abstracts highlighting long-term clinical outcomes and impact on overall survival of AYVAKIT® (avapritinib) in...

-- ASH abstract contains previously presented data from June 2022 -- -- New clinical data from a recent data cut will be presented at ASH -- -- Company to host a live webcast event with an expert...

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the...

Lennox International Inc. (NYSE: LII), a leader in energy-efficient climate-control solutions, today announced that CEO Alok Maskara and CFO Joe Reitmeier are scheduled to present at the Baird...

Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that study investigators will present data from the BRUIN Phase 1/2 trial of pirtobrutinib at the American...

The 2nd Global Forum of People's Organizations on Hansen's Disease takes place in Hyderabad, India, from November 6 to 8, 2022. Organized by Sasakawa Leprosy (Hansen's Disease) Initiative as part...